Viewing Study NCT07037758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-02-22 @ 9:38 AM
Study NCT ID: NCT07037758
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extensive Stage Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ES-SCLC View
None Tarlatamab View
None AMG 757 View
None AB248 View
None Imdelltra View